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Technical Details about bfGWAS 1 Bayesian Hierarchical Model
Standard Bayesian Variable Selection Regression Model
Consider the following standard Bayesian variable selection regression (BVSR) model
where y n×1 denotes the centered phenotype vector of n samples; X n×p denotes the centered genotype matrix of p genetic variants; i denotes the residual error independently and identically distributed (i.i.d.) with normal distribution N (0, τ −1 ); and β i follows a spike-and-slab prior distribution [5, 6, 7] -that is, β i follows the normal distribution N (0, τ −1 σ 2 i ) with probability π i and the point-mass density function δ 0 (·) at 0 with probability (1 − π i ) (δ 0 (β i ) = 1 if β i = 0, otherwise δ 0 (β i ) = 0).
Here, the genotype matrix contains either dosage data within range [0, 2] or genotype data with values {0, 1, 2} denoting the number of minor alleles. The assumption of the spike-and-slab prior for β i enforces variable selection in the regression model (1) . We drop the intercept term here for assuming both y n×1 and columns of X n×p are centered. Although this model is developed for quantitative trait, we can treat dichotomous traits (e.g., cases and controls) as quantitative with values of 1 and 0 (e.g., 1 for cases and 0 for controls), which was proven to be equivalent as using the logistic or probit model by previous approaches [6, 7] .
Integrating Functional Information
In this paper, we only consider non-overlapped categorical annotations. Let A i = (A i1 , · · · , A iQ )
T denotes the vector of Q annotations for the ith variant, where A iq takes binary values (1/0) to denote whether the ith variant is of the qth annotation. In order to integrate functional annotations into the standard BVSR model (1), we assume all variants of annotation q have the same spike-and-slab prior with parameters (π q , σ 2 q ). We further assume the following independent and conjugate hyper priors (Figure S 1(A)):
where Beta(a q , b q ) denotes a Beta distribution with positive shape parameters a q and b q , IG(k 1 , k 2 ) denotes an Inverse-Gamma distribution with shape parameter k 1 and scale parameter k 2 , and G(k 3 , k 4 ) denotes a Gamma distribution with shape parameter k 3 and scale parameter k 4 ( Figure S1 (A)). Note that parameters (a q , b q ) could be different with respect to different annotations. This hierarchical BVSR model is equivalent to the standard BVSR model when modeling no functional information (i.e., assuming the same π q and σ 2 q for all variants). In order to adjust for the unbalance distribution of functional annotations among all variants and encourage for a sparse model, we choose values for a q and b q such that the mean of the Beta distribution aq aq+bq = 10 −6 with (a q + b q ) = m q = p i=1,j=q A ij (the total number of variants of annotation q). Here, the mean 10 −6 of Beta(a q , b q ) helps enforce a sparse initial model that is desired for controlling false positives (assuming one signal per1M variants). We take k 1 = k 2 = k 3 = k 4 = 0.1 to induce non-informative priors on σ 2 q and τ . Thus, the posterior estimates of π q and σ 2 q will mainly depend on the data likelihood. However, when there are few association signals in the qth category, the posterior estimates of π q and σ 2 q ) will be set as their respective prior modes. Note that although the hyper priors are assumed to be independent, the posterior distributions of π q and σ 2 q are no longer independent.
Latent Indicator Variable
To facilitate computation, we introduce a latent indicator vector γ p×1 [5] into the model, where each element γ i ∈ {0, 1} indicates whether the corresponding ith effect β i equals to 0 with γ i = 0 or follows the N (0, τ −1 σ 2 i ) distribution with γ i = 1. Equivalently,
where |γ| denotes the number of non-zero entries in γ; β −γ denotes the sub-vector of β p×1 corresponding to variants with γ i = 0; β γ denotes the sub-vector of β p×1 corresponding to the variants with {γ j = 1; j = 1, · · · , |γ|}; and V |γ| is the corresponding sub-matrix (with
Bayesian Inference
With the above Bayesian hierarchical model, the posterior joint distribution of (β, γ, σ 2 , π, τ ) is proportional to the product of likelihood and prior density functions,
where
, and A is the p × Q annotation matrix with binary values. Now our goal is to make inference on the category-specific parameters (π, σ 2 )
and the variable-specific parameters (β, E[γ]) from their respective marginal posterior distributions, conditioning on the data (y, X, A). The category-specific parameters (π, σ 2 )
denote the shared characteristics of variants with the same annotation, which are also referred as enrichment parameters in this paper. Specifically, π q denotes the causality for variants of annotation q, and σ 2 q denotes the effect-size variance for associated variants (with nonzero β j ) of annotation q.
To make the Bayesian inference of our model applicable for genome-wide analysis, we pair it with a novel Expectation-Maximization Markov chain Monte Carlo (EM-MCMC) algorithm. Because of the block-wise linkage disequilibrium (LD) structure of human genome, we can segment the genotype data X into K approximately independent blocks, i.e., X = {X 1 , X 2 , · · · , X K }, where each submatrix X k has dimension n × p k (genotypes of p k variants for n samples). Thus, we can write the likelihood function in (3) as a product of a series likelihood functions for X k ,
To avoid adjusting for the residual variance with respect to each genome-block, we fix τ −1 as the phenotype variance. This assumption is reasonable because most genomeblocks explain little phenotype variance in practice. Although fixing τ −1 as the phenotype variance seems conservative for genome-blocks with true signals, our analysis showed that it barely affect identifying true signals.
In the Expectation step (E-step), (β k , E[γ k ]) are estimated by implementing MCMC per block, conditioning on the given values of (π, σ); in the Maximization step (M-step), (π, σ) are updated, conditioning on genome-wide estimates of (β, E[γ]) from the E-step. In general, ∼5 EM iterations will lead to convergent estimates of (π, σ), and the estimates of (β k , E[γ k ]) from the last E-step will be used to identify association signals (details are provided in Section 2; Figure S 1(B) ).
Conditional Posterior Distribution for β k
Conditioning on the values of (π, σ 2 , τ ), the posterior distribution for the variant-specific
Conditioning on the indicator vector γ k , the effect-sizes associated with zero indicator variables are 0, while the posterior distribution for β |γ k | is given by
From (6), it is easy to see that
Here, the subscript |γ k | indicates sub-matrices or sub-vectors corresponding to variants with nonzero indicator variables, and V |γ k | is a diagonal matrix with (V |γ k | ) jj = σ 2 q if the jth variant is of annotation q.
Conditional Posterior Distribution for γ k
Because of the conditional conjugate prior for β k , we can easily integrate β k out from the joint conditional posterior distribution (5) to obtain the marginal conditional posterior distribution for γ k ,
EM-MCMC Algorithm
The steps of the EM-MCMC algorithm are as follows:
(i) Fix τ at the value of phenotype variance;
(ii) Set initial values for the category-specific parameters (π, σ 2 );
(iii) E-step: Conditioning on the most recent values of (π, σ 2 ), estimate variant-specific parameters (β, E[γ]) by implementing MCMC per block;
(iv) M-step: Conditioning on the genome-wide estimates of (β, E[γ]) from the previous E-step, update (π, σ 2 ) by their MAPs (maximum a posteriori estimates), maximizing the expected log-posterior-likelihood functions [2] ;
(v) Repeat the EM-steps (iii) and (iv) for a few times until the MAPs of (π, σ 2 ) converge.
Setup Initial Values
In this paper, we fix τ at the value of phenotype variance, equivalent to assuming no phenotype variance explained by the genetic variants. This assumption is true for most blocks and slightly conservative for blocks with true signals. However, our analysis showed that this assumption barely affects identifying true signals. We take initial values π q = 1 × 10 −6 to initial a sparse and conservative model, and σ 2 q = 10 to start with a large effect-size variance for all associated variants.
MCMC Sampling Scheme
The MCMC sampling is implemented per block for estimating (β k , E[γ k ]), conditioning on category-specific parameters (π, σ 2 ):
(i) First, sort all variants in the block by their base positions, perform single variant tests, and rank variants based on their marginal association evidence (e.g., P-values) from strong to weak.
(ii) Second, select an initial model with independent significant signals. We first include the variant with the smallest P-value into the model (i.e., set the corresponding indicator value as 1). Then, conditioning on the currently selected variant(s), select the next most significant variant with P-value < 5 × 10 −8 . Stop selection when no other independent genome-wide signal exists. Generally, most of the blocks with ∼10K variants will start with only one variant.
(iii) Third, repeat the MCMC sampling for a large number of iterations (e.g., 50K iterations with 50K burnins), in which the Metropolis-Hastings algorithm is used to draw posterior samples for γ k based on (8). With indicator vector γ k and corresponding effect-size vector β |γ k | from previous iteration, each MCMC iteration is as follows:
(a) Randomly propose a new indicator vector γ k by: * Including an extra variant into the model with probability 1/3: generate a rank r from a proposal distribution P γ k such that the variant with rank r is not included in the current model (change the corresponding indicator variable from 0 to 1). Here, P γ k is constructed as the mixture distribution 0.9 * U top +0.1U rest , where U top denotes the uniform distribution on top ranks (1, . . . , t k ) and U rest denotes the uniform distribution on the remain ranks (t k+1 , · · · , p k ) (t k is an arbitrary number). That is, we assume a variant whose P-value is ranked in the top association group will be proposed with probability 0.9/(t k ), while a variant in the remaining group will be proposed with probability 0.1/(p k − t k ). A rank will keep being proposed from P γ k until the corresponding variant is absent in the current model. We take t k = min(p k , 300) in our software. * Deleting a variant from the current model with probability 1/3: randomly delete a variant from the current model (change the corresponding indicator variable from 1 to 0), i.e., each variant in the current model has probability 1/|γ k | to be deleted. exp(s b − s max ) as the probability for the corresponding jth variant to be proposed. The neighborhood size can be tuned by users (we set the neighborhood window as 100 variants near the switch candidate in our analyses).
(b) Conditioning on the indicator vector γ k , the effect-size vector β |γ k | is estimated by its conditional posterior mean in (7).
(c) Calculate the Metropolis-Hastings acceptance ratio, and then decide whether to accept or reject γ k by the Metropolis-Hastings algorithm.
(iv) Finally, E[γ kj ] is estimated by u kj /M , where u kj is the number of times when the jth variant in block k is included into the model and M is the total MCMC iterations.
Note that E[γ kj ] is also referred as the Bayesian posterior inclusion probability (PP), evidence for the ith variant in block k to be an association signal. The Bayesian estimate of the corresponding β kj is given by the posterior mean u kj l=1 β kjl /u kj , where β kjl is the effect-size estimate for the jth variant (in block k) when it is included into the model for the lth time.
Within the MCMC sampling, we also record the number of iterations M active when the linear regression model includes at least one variant by the Metropolis-Hastings algorithm. Then the proportion of such MCMC iterations M active /M gives us the regional posterior inclusion probability (regional-PP) of the study block, which is the probability of existing at least one signal in the block. Because variants in high LD and the same annotation category have the same chance to be included into the linear model (splitting the posterior probability for a single signal), the regional-PP is more appropriate than the single variant Bayesian PP for claiming a risk locus.
EM Algorithm
In the EM algorithm, values of (π, σ 2 ) are updated by their respective maximum a posteriori estimates (MAPs), maximizing expected log-posterior-likelihood functions. With the Bayesian estimates of (β, E[γ]) from the E-step, the expected log-posterior-likelihood functions and MAPs can be derived with closed-form expressions.
MAP for σ 2
From the joint posterior distribution (3), the conditional posterior density function (posterior likelihood) of σ 2 becomes
The expected log-posterior-likelihood of σ 2 is given by
Bayesian estimates by MCMC in the E-step, and C is a constant free of σ 2 .
From (10), we can see that the posterior distributions of {σ 2 q ; q = 1, . . . , Q} are disjoint, because of independent priors and non-overlapped annotations. Thus, the expected logposterior-likelihood function for each σ 2 q is
where { γ jq , β jq ; j q = 1, . . . , n q } are the Bayesian estimates for variants of annotation q, and m q is the total number of variants with annotation q. The MAP of σ 2 q can be solved from
.
MAP for π
From the joint posterior distribution (3), the conditional posterior density function (posterior likelihood) of π becomes
The expected log-posterior-likelihood of π can be derived as
where { γ i = E[γ i ]} are estimated by MCMC, and C is a constant free of π.
Similarly, because the posterior distributions of {π q ; q = 1, . . . , Q} are also disjoint, the expected log-posterior-likelihood function for π q is given by
and the MAP for π q is solved as
Construct Confidence Intervals by Fisher Information
Fisher information of (π, σ 2 ) can be derived from the second derivatives of the respective expected log-posterior-likelihood functions as in (11) and (13). By the asymptoticnormality of MAP, as n → ∞, the distribution of a MAP estimate θ converges to a multivariate normal (MVN) distribution with mean equal to the true parameter value θ 0 and covariance matrix equal to the inverse of the Fisher information. Therefore, the MAPs σ 2 and π are converging to the following MVN distributions as n → ∞,
where σ 2 * and π * are the true parameter values;
Because of the mutual independence among {σ 2 q , π q ; q = 1, . . . , Q} (conditioning on the estimates of β and E[γ]), the analytical forms for the second derivatives of l σ 2 q , l πq are
Then the Fisher informations of σ 2 q , π q are given by
The (1 − α)% confidence intervals of σ 2 q , π q can be constructed by
where Z α/2 is the upper α/2 quantile of the standard normal distribution N (0, 1).
Compare Enrichment among Multiple Groups
With the MAPs of (π q , σ 2 q ) and corresponding standard errors, we can easily compare the enrichment among multiple groups. Take the case with two annotation groups for an example, the 95% confidence intervals of the quantities ln(π 1 /π 2 ), ln(σ
, and then can be used to test whether or not the enrichment is significantly different between two groups (i.e. whether or not the 95% confidence intervals of ln(π 1 /π 2 ), ln(σ 2 1 /σ 2 2 ) overlap 0). Moreover, with the approximated variance of the log-ratio by Fieller's theorem, we can calculate a P-value for the null hypothesis that the log-ratio equals 0. For example, the P-value for testing the null hypothesis ln(π 1 /π 2 ) = 0 vs. the alternative hypothesis ln(π 1 /π 2 ) = 0 can be calculated by
where Ψ is the probability distribution function of N (0, 1), ( π 1 , π 2 ) are MAPs, and
For the case with multiple annotation groups, we can calculate similar quantities to compare the estimates by each group vs. the genome-wide average. That is, for causal probability, ln(π q /π avg ) is used to test whether or not the causal probability of group q is significantly different from the overall average, where
is the number of variants of annotation q). For the effect-size variance, a similar quantity ln(σ (m q π q is the expected number of associations in annotation category q). Again, the hypothesis tests for comparing enrichment among multiple groups can be easily performed, because the approximated 95% confidence intervals of these log-ratios can be easily obtained by Fieller's theorem [3] .
In addition, we can approximate the enrichment-fold π 1 /π 2 by exp(ln(π 1 /π 2 )), and σ 
Convergence Diagnosis
We used the potential scale reduction factor (PSRF) [4] to quantify the mixing property of MCMC algorithms. With multiple MCMC chains, the PSRF for a parameter is basically the ratio between the overall estimated parameter variance and the within-chain variance. A PSRF value within (0.9, 1.2) suggests that the MCMC algorithm has good mixing property and posterior samples converge. For example, in Figure S2 , we present the PSRFs for the E[γ i ] of top 58 variants with P-values < 5 × 10 −8 in the WTCCC GWAS of Chrohn's disease [1] . We can see that about half of the 58 variants had PSRFs > 1.2 by the standard MCMC algorithm as used in GEMMA [7] , while all PSRFs by our MCMC algorithm all fall within (0.9, 1.2), suggesting greatly improved mixing property due to the refined proposal distribution and relatively small block-sizes.
Challenges for Extending bfGWAS for Overlapped and Quantitative Annotations
Theoretically, this Bayesian hierarchical model can be easily extended for analyzing overlapped categorical and quantitative annotations, by assuming the following logistic model for the π i in model (1),
In the logistic model (17), A i is the quantitative annotation vector (with binary values for categorical annotations) for the ith variant, and α = (α 1 , · · · , α Q ) is the vector of logodds for all considered annotations. Independent normal distributions can be assumed as the hyper priors for the category-specific (enrichment) parameters (α 0 , α). With a large number of annotations, variable selection of annotations might even be integrated by assuming independent point-normal priors for α.
Conditioning on values for (α 0 , α), the MCMC algorithm (Section 2.2) can be implemented similarly per block in the E-step. However, in the M-step, analytical formulas are no longer available for the posterior MAPs of (α 0 , α). In preliminary analysis, we found that the false positive rate was inflated due to over estimated π i , which is due to the difficulties of estimating (α 0 , α). We are still exploring an appropriate approach to effectively control the false positive rate for this extension.
Software
Software implementing this Bayesian hierarchical model with the EM-MCMC algorithm, referred as Bayesian Functional Genome-wide Association Study (bfGWAS), is now available at GitHub (https://github.com/yjingj/bfGWAS). Within the software, the Estep (MCMC algorithm) is written in C++ language; the M-step is written in an R script; and both steps are wrapped together (enabling parallel computation) through submitting jobs by a Makefile that is generated by a Perl script. Figure S 1 : Flowcharts of bfGWAS. (B)
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